Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
暂无分享,去创建一个
J M Esteban | L E Williams | A A Raubitschek | M. Neumaier | J. Wong | A. Wu | T. Odom-Maryon | J. Shively | F. J. Primus | L. Williams | J. Esteban | M Neumaier | A M Wu | A. Raubitschek | F J Primus | A. Raubitschek | A Liu | J E Shively | J Y Wong | D Yamauchi | T L Odom-Maryon | G E Thomas | S Dresse | G. Thomas | D. Yamauchi | A. Liu | S. Dresse | F. Primus
[1] H. Hansen,et al. Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. , 1974, Human pathology.
[2] C. Wagener,et al. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies. , 1983, Journal of immunology.
[3] C. Wagener,et al. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay. , 1983, Journal of immunology.
[4] K. Foon,et al. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. , 1985, Cancer research.
[5] A. Epenetos. Antibody guided lymphangiography in the staging of cervical cancer. , 1985, British Journal of Cancer.
[6] R. W. Baldwin,et al. The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] M. Larché,et al. Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. , 1986, Cancer research.
[8] R. Paxton,et al. Preoperative imaging of colorectal carcinoma with 111In-labeled anticarcinoembryonic antigen monoclonal antibody. , 1986, Cancer research.
[9] C. Higano,et al. Colorectal carcinoma: detection with indium-111 anticarcinoembryonic-antigen monoclonal antibody ZCE-025. , 1987, Radiology.
[10] J. Schlom,et al. Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. , 1988, Cancer research.
[11] R. Paxton,et al. Tumor uptake as a function of tumor mass: a mathematic model. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] J. Murray,et al. Improved tumor localization with increasing dose of indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. Ghrayeb,et al. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[14] R. Paxton,et al. Effect of specific antibody pretreatment on liver uptake of 111In-labeled anticarcinoembryonic antigen monoclonal antibody in nude mice bearing human colon cancer xenografts. , 1989, Cancer research.
[15] S. Stroupe,et al. An optimized antibody-chelator conjugate for imaging of carcinoembryonic antigen with indium-111. , 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[16] R. Paxton,et al. Estimation of monoclonal antibody-associated 90Y activity needed to achieve certain tumor radiation doses in colorectal cancer patients. , 1990, Cancer research.
[17] A. Riggs,et al. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells. , 1990, Cancer research.
[18] J. Ajani,et al. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] J. Beatty,et al. Comparison of immunoscintigraphy and computerized tomography in identifying colorectal cancer: individual lesion analysis. , 1991, Cancer research.
[20] J. Beatty,et al. Intraoperative gamma detection probe with presurgical antibody imaging in colon cancer. , 1991, Archives of surgery.
[21] A. Delaloye,et al. Diagnostic Applications and Therapeutic Approaches with Different Preparations of Anti-CEA Antibodies , 1992, The International journal of biological markers.
[22] R. V. Van Heertum,et al. Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] A. Maraveyas,et al. Asbestos fibers in the colonic wall. , 1974, British Journal of Cancer.
[24] M. Kaminski,et al. Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody. , 1993, The New England journal of medicine.
[25] Chen-feng Qi,et al. Definition of the expression of the human carcinoembryonic antigen and non‐specific cross‐reacting antigen in human breast and lung carcinomas , 2009, International journal of cancer.
[26] J. Wong,et al. A method including edge effects for the estimation of radioimmunotherapy absorbed doses in the tumor xenograft model. , 1994, Medical physics.
[27] J. Simpson,et al. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients , 1994, Cancer.
[28] J. Ryser,et al. Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody for surgically treated colorectal carcinoma. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[29] M. Schrappe,et al. A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. , 1995, European journal of cancer.
[30] J M Esteban,et al. Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial. , 1995, Cancer research.
[31] G. Curt,et al. Phase I trial of iodine 131-labeled COL-1 in patients with gastrointestinal malignancies: influence of serum carcinoembryonic antigen and tumor bulk on pharmacokinetics. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] M G Stabin,et al. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.